Duplication of the MYB oncogene in T cell acute lymphoblastic leukemia

Lahortiga, Idoya;De Keersmaecker, Kim;Van Vlierberghe, Pieter;Graux, Carlos;Cools, Jan;et.al.
(2007) Nature Genetics — Vol. 39, n° 5, p. 593-595 (2007)

Files

37619.pdf
  • Restricted Access
  • Adobe PDF
  • 2.64 MB

Details

Authors
  • Lahortiga, Idoya
    Author
  • De Keersmaecker, Kim
    Author
  • Van Vlierberghe, Pieter
    Author
  • Graux, CarlosUCLouvain
    Author
  • Cools, Jan
    Author
Show more
Abstract
We identified a duplication of the MYB oncogene in 8.4% of individuals with T cell acute lymphoblastic leukemia (T-ALL) and in five T-ALL cell lines. The duplication is associated with a threefold increase in MYB expression, and knockdown of MYB expression initiates T cell differentiation. Our results identify duplication of MYB as an oncogenic event and suggest that MYB could be a therapeutic target in human T-ALL.
Affiliations

Citations

Lahortiga, I., De Keersmaecker, K., Van Vlierberghe, P., Graux, C., Cauwelier, B., Lambert, F., Mentens, N., Beverloo, H. B., Pieters, R., Speleman, F., Odero, M. D., Bauters, M., Froyen, G., Marynen, P., Vandenberghe, P., Wlodarska, I., Meijerink, J. P. P., & Cools, J. (2007). Duplication of the MYB oncogene in T cell acute lymphoblastic leukemia. Nature Genetics, 39(5), 593-595. https://doi.org/10.1038/ng2025 (Original work published 2007)